In the last 3 years, Consonance Capital Partners has acquired 1 company.
Consonance Capital Partners’ most common sectors for investment are healthcare services (60%) and life science (20%). The Firm’s most common investment types include divestiture (60%) and going private (20%). In total, Consonance Capital Partners has invested in 4 US states.
In the last 3 years, Consonance Capital Partners has exited 2 companies. The Firm’s most common exit type is trade sale (50%). Consonance Capital Partners’ largest (disclosed) exit occurred in 2019 when it sold Corindus Vascular Robotics for $1.1B.
Join Mergr to view Consonance Capital Partners’ full profile and discover more middle-market private equity firms just like it.
Consonance Capital Partners is a healthcare focused private investment firm focused on both public and private equity investing. The Firm's private equity group targets growth equity, leveraged buyouts, and recapitalization transactions in lower middle-market companies with $20 to $150 million of revenue. Specific areas of interest include healthcare providers, mayors, distribution, medical devices, specialty pharmaceuticals, outsourced services, and healthcare IT. Consonance Capital Partners was formed in 2005 and is based in New York City.
Join Mergr to view the latest updates and news from Consonance Capital Partners.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.